Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

GEORGE ISAAC

NPI
1588652416
CMS profile
207991
Location
DUBUQUE, IA

General Payments · PY2018–2024

$5,836.47

  • Reported across 365 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$692.79

36 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $692.79 36

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Amgen Inc. $210.56 13
ABBVIE INC. $99.07 4
UCB, Inc. $76.29 3
Boehringer Ingelheim Pharmaceuticals, Inc. $74.04 3
Mallinckrodt Hospital Products Inc. $57.54 3
Organon LLC $39.57 3
Janssen Biotech, Inc. $39.16 2
PFIZER INC. $33.61 2
Genentech USA, Inc. $27.73 1
Acerta Pharma LLC $19.22 1
Almatica Pharma Inc. $16.00 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $966.26 74
PY2019 $891.21 65
PY2020 $698.51 40
PY2021 $848.18 54
PY2022 $1,090.66 63
PY2023 $648.86 33
PY2024 $692.79 36

Payment records · PY2024 (36)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $18.16 01/20/2024 Food and Beverage Undisputed 01/23/2026 1103970715 CMS
ABBVIE INC. $32.40 04/20/2024 Food and Beverage Undisputed 01/23/2026 1103970717 CMS
ABBVIE INC. $29.61 07/23/2024 Food and Beverage Undisputed 01/23/2026 1103970719 CMS
ABBVIE INC. $18.90 10/21/2024 Food and Beverage Undisputed 01/23/2026 1103970721 CMS
Almatica Pharma LLC $16.00 07/19/2024 Food and Beverage Undisputed 01/23/2026 1137566338 CMS
Amgen Inc. $11.75 01/29/2024 Food and Beverage Undisputed 01/23/2026 1111605781 CMS
Amgen Inc. $15.20 02/12/2024 Food and Beverage Undisputed 01/23/2026 1117284803 CMS
Amgen Inc. $15.00 03/18/2024 Food and Beverage Undisputed 01/23/2026 1111605783 CMS
Amgen Inc. $17.23 04/09/2024 Food and Beverage Undisputed 01/23/2026 1111605789 CMS
Amgen Inc. $14.98 05/13/2024 Food and Beverage Undisputed 01/23/2026 1111605785 CMS
Amgen Inc. $16.84 06/03/2024 Food and Beverage Undisputed 01/23/2026 1117284805 CMS
Amgen Inc. $15.61 07/11/2024 Food and Beverage Undisputed 01/23/2026 1111605775 CMS
Amgen Inc. $24.04 07/15/2024 Food and Beverage Undisputed 01/23/2026 1111605791 CMS
Amgen Inc. $22.53 07/29/2024 Food and Beverage Undisputed 01/23/2026 1111605787 CMS
Amgen Inc. $14.72 09/23/2024 Food and Beverage Undisputed 01/23/2026 1117284807 CMS
Amgen Inc. $11.73 09/30/2024 Food and Beverage Undisputed 01/23/2026 1111605777 CMS
Amgen Inc. $19.45 10/14/2024 Food and Beverage Undisputed 01/23/2026 1111605793 CMS
Amgen Inc. $11.48 11/11/2024 Food and Beverage Undisputed 01/23/2026 1111605779 CMS
AstraZeneca Pharmaceuticals LP $19.22 12/06/2024 Food and Beverage Undisputed 01/23/2026 1110545769 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $25.01 03/11/2024 Food and Beverage Undisputed 01/23/2026 1118070302 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $23.39 06/17/2024 Food and Beverage Undisputed 01/23/2026 1118070300 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $25.64 11/04/2024 Food and Beverage Undisputed 01/23/2026 1118070304 CMS
Genentech USA, Inc. $27.73 03/01/2024 Food and Beverage Undisputed 01/23/2026 1133014554 CMS
Janssen Biotech, Inc. $19.16 05/20/2024 Food and Beverage Undisputed 01/23/2026 1078564495 CMS
Janssen Biotech, Inc. $20.00 08/20/2024 Food and Beverage Undisputed 01/23/2026 1078564491 CMS
Mallinckrodt Hospital Products Inc. $20.24 06/10/2024 Food and Beverage Undisputed 01/23/2026 1145086290 CMS
Mallinckrodt Hospital Products Inc. $19.60 09/16/2024 Food and Beverage Undisputed 01/23/2026 1145086295 CMS
Mallinckrodt Hospital Products Inc. $17.70 12/10/2024 Food and Beverage Undisputed 01/23/2026 1145086299 CMS
Organon Llc $11.90 01/08/2024 Food and Beverage Undisputed 01/23/2026 1136231202 CMS
Organon Llc $14.73 04/22/2024 Food and Beverage Undisputed 01/23/2026 1136231206 CMS
Organon Llc $12.94 11/25/2024 Food and Beverage Undisputed 01/23/2026 1136231210 CMS
PFIZER INC. $19.41 01/23/2024 Food and Beverage Undisputed 01/23/2026 1130974724 CMS
PFIZER INC. $14.20 09/13/2024 Food and Beverage Undisputed 01/23/2026 1131936146 CMS
UCB, Inc. $31.23 04/05/2024 Food and Beverage Undisputed 01/23/2026 1143026566 CMS
UCB, Inc. $22.57 06/22/2024 Food and Beverage Undisputed 01/23/2026 1143026568 CMS
UCB, Inc. $22.49 09/20/2024 Food and Beverage Undisputed 01/23/2026 1143026570 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.